OT03 | BGB‐11417‐302, A PHASE 3, RANDOMIZED, DOUBLE‐BLIND STUDY OF SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB VERSUS PLACEBO + ZANUBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA Article Swipe
M. Dreyling
,
Marc A. Hughes
,
Toby A. Eyre
,
Yuqin Song
,
Yanan Wang
,
Junhua Zhang
,
H. Alalade
,
Elena Maksimova
,
Xinyu Li
,
Zhiheng Xu
,
Chi Ho To
,
Limei Wang
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/hon.70093_ot03
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/hon.70093_ot03
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/hon.70093_ot03
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411393419
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411393419Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/hon.70093_ot03Digital Object Identifier
- Title
-
OT03 | BGB‐11417‐302, A PHASE 3, RANDOMIZED, DOUBLE‐BLIND STUDY OF SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB VERSUS PLACEBO + ZANUBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMAWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-01Full publication date if available
- Authors
-
M. Dreyling, Marc A. Hughes, Toby A. Eyre, Yuqin Song, Yanan Wang, Junhua Zhang, H. Alalade, Elena Maksimova, Xinyu Li, Zhiheng Xu, Chi Ho To, Limei WangList of authors in order
- Landing page
-
https://doi.org/10.1002/hon.70093_ot03Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03Direct OA link when available
- Concepts
-
Placebo, Refractory (planetary science), Double blind, Mantle cell lymphoma, Medicine, Internal medicine, Lymphoma, Pathology, Biology, Astrobiology, Alternative medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411393419 |
|---|---|
| doi | https://doi.org/10.1002/hon.70093_ot03 |
| ids.doi | https://doi.org/10.1002/hon.70093_ot03 |
| ids.openalex | https://openalex.org/W4411393419 |
| fwci | 0.0 |
| type | article |
| title | OT03 | BGB‐11417‐302, A PHASE 3, RANDOMIZED, DOUBLE‐BLIND STUDY OF SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB VERSUS PLACEBO + ZANUBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA |
| biblio.issue | S3 |
| biblio.volume | 43 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11157 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Chronic Lymphocytic Leukemia Research |
| topics[1].id | https://openalex.org/T10185 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.996999979019165 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Lymphoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T11811 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9476000070571899 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2708 |
| topics[2].subfield.display_name | Dermatology |
| topics[2].display_name | Cutaneous lymphoproliferative disorders research |
| is_xpac | False |
| apc_list.value | 4220 |
| apc_list.currency | USD |
| apc_list.value_usd | 4220 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C27081682 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5585132241249084 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[0].display_name | Placebo |
| concepts[1].id | https://openalex.org/C142424586 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5037128329277039 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[1].display_name | Refractory (planetary science) |
| concepts[2].id | https://openalex.org/C2991744798 |
| concepts[2].level | 4 |
| concepts[2].score | 0.49758246541023254 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q608510 |
| concepts[2].display_name | Double blind |
| concepts[3].id | https://openalex.org/C2777525834 |
| concepts[3].level | 3 |
| concepts[3].score | 0.483194500207901 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q268713 |
| concepts[3].display_name | Mantle cell lymphoma |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.46644163131713867 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.36205020546913147 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2779338263 |
| concepts[6].level | 2 |
| concepts[6].score | 0.22339856624603271 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[6].display_name | Lymphoma |
| concepts[7].id | https://openalex.org/C142724271 |
| concepts[7].level | 1 |
| concepts[7].score | 0.10274553298950195 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[7].display_name | Pathology |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.07769343256950378 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C87355193 |
| concepts[9].level | 1 |
| concepts[9].score | 0.04695191979408264 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q411 |
| concepts[9].display_name | Astrobiology |
| concepts[10].id | https://openalex.org/C204787440 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[10].display_name | Alternative medicine |
| keywords[0].id | https://openalex.org/keywords/placebo |
| keywords[0].score | 0.5585132241249084 |
| keywords[0].display_name | Placebo |
| keywords[1].id | https://openalex.org/keywords/refractory |
| keywords[1].score | 0.5037128329277039 |
| keywords[1].display_name | Refractory (planetary science) |
| keywords[2].id | https://openalex.org/keywords/double-blind |
| keywords[2].score | 0.49758246541023254 |
| keywords[2].display_name | Double blind |
| keywords[3].id | https://openalex.org/keywords/mantle-cell-lymphoma |
| keywords[3].score | 0.483194500207901 |
| keywords[3].display_name | Mantle cell lymphoma |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.46644163131713867 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.36205020546913147 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/lymphoma |
| keywords[6].score | 0.22339856624603271 |
| keywords[6].display_name | Lymphoma |
| keywords[7].id | https://openalex.org/keywords/pathology |
| keywords[7].score | 0.10274553298950195 |
| keywords[7].display_name | Pathology |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.07769343256950378 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/astrobiology |
| keywords[9].score | 0.04695191979408264 |
| keywords[9].display_name | Astrobiology |
| language | en |
| locations[0].id | doi:10.1002/hon.70093_ot03 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S23714410 |
| locations[0].source.issn | 0278-0232, 1099-1069 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0278-0232 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Hematological Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Hematological Oncology |
| locations[0].landing_page_url | https://doi.org/10.1002/hon.70093_ot03 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5052396392 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | M. Dreyling |
| authorships[0].countries | DE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I3018771216, https://openalex.org/I8204097 |
| authorships[0].affiliations[0].raw_affiliation_string | Medizinische Klinik III Klinikum der Universität LMU München Munich Germany |
| authorships[0].institutions[0].id | https://openalex.org/I3018771216 |
| authorships[0].institutions[0].ror | https://ror.org/02jet3w32 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I3018771216, https://openalex.org/I8204097 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | LMU Klinikum |
| authorships[0].institutions[1].id | https://openalex.org/I8204097 |
| authorships[0].institutions[1].ror | https://ror.org/05591te55 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I8204097 |
| authorships[0].institutions[1].country_code | DE |
| authorships[0].institutions[1].display_name | Ludwig-Maximilians-Universität München |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | M. Dreyling |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Medizinische Klinik III Klinikum der Universität LMU München Munich Germany |
| authorships[1].author.id | https://openalex.org/A5063933587 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3652-3412 |
| authorships[1].author.display_name | Marc A. Hughes |
| authorships[1].countries | NZ |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210098492 |
| authorships[1].affiliations[0].raw_affiliation_string | Tauranga Hospital Tauranga New Zealand |
| authorships[1].institutions[0].id | https://openalex.org/I4210098492 |
| authorships[1].institutions[0].ror | https://ror.org/00yr70j54 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210098492 |
| authorships[1].institutions[0].country_code | NZ |
| authorships[1].institutions[0].display_name | Tauranga Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | M. Hughes |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Tauranga Hospital Tauranga New Zealand |
| authorships[2].author.id | https://openalex.org/A5053298824 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6631-9749 |
| authorships[2].author.display_name | Toby A. Eyre |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2801179840 |
| authorships[2].affiliations[0].raw_affiliation_string | Oxford Cancer and Haematology Centre Churchill Hospital Headington Oxford UK |
| authorships[2].institutions[0].id | https://openalex.org/I2801179840 |
| authorships[2].institutions[0].ror | https://ror.org/009vheq40 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2801179840, https://openalex.org/I4210147381 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Churchill Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | T. A. Eyre |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Oxford Cancer and Haematology Centre Churchill Hospital Headington Oxford UK |
| authorships[3].author.id | https://openalex.org/A5037498466 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5451-6481 |
| authorships[3].author.display_name | Yuqin Song |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I20231570, https://openalex.org/I4210093964 |
| authorships[3].affiliations[0].raw_affiliation_string | Peking University Cancer Hospital and Institute Beijing China |
| authorships[3].institutions[0].id | https://openalex.org/I20231570 |
| authorships[3].institutions[0].ror | https://ror.org/02v51f717 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I20231570 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Peking University |
| authorships[3].institutions[1].id | https://openalex.org/I4210093964 |
| authorships[3].institutions[1].ror | https://ror.org/00nyxxr91 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210093964 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | Peking University Cancer Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Y. Song |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Peking University Cancer Hospital and Institute Beijing China |
| authorships[4].author.id | https://openalex.org/A5100385353 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7401-047X |
| authorships[4].author.display_name | Yanan Wang |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1330342723 |
| authorships[4].affiliations[0].raw_affiliation_string | Mayo Clinic Rochester Minnesota USA |
| authorships[4].institutions[0].id | https://openalex.org/I1330342723 |
| authorships[4].institutions[0].ror | https://ror.org/02qp3tb03 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1330342723 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Mayo Clinic |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Y. Wang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Mayo Clinic Rochester Minnesota USA |
| authorships[5].author.id | https://openalex.org/A5100377750 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4043-1967 |
| authorships[5].author.display_name | Junhua Zhang |
| authorships[5].affiliations[0].raw_affiliation_string | BeiGene USA, Inc San Mateo California USA |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | J. Zhang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | BeiGene USA, Inc San Mateo California USA |
| authorships[6].author.id | https://openalex.org/A5118277991 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | H. Alalade |
| authorships[6].affiliations[0].raw_affiliation_string | BeiGene USA, Inc San Mateo California USA |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | H. Alalade |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | BeiGene USA, Inc San Mateo California USA |
| authorships[7].author.id | https://openalex.org/A5102792600 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8729-6526 |
| authorships[7].author.display_name | Elena Maksimova |
| authorships[7].affiliations[0].raw_affiliation_string | BeiGene USA, Inc San Mateo California USA |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | E. Maksimova |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | BeiGene USA, Inc San Mateo California USA |
| authorships[8].author.id | https://openalex.org/A5073516436 |
| authorships[8].author.orcid | https://orcid.org/0009-0000-6225-3263 |
| authorships[8].author.display_name | Xinyu Li |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210100450 |
| authorships[8].affiliations[0].raw_affiliation_string | BeiGene (Shanghai) Co, Ltd Shanghai China |
| authorships[8].institutions[0].id | https://openalex.org/I4210100450 |
| authorships[8].institutions[0].ror | https://ror.org/012v2c923 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210100450 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | BeiGene (China) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | X. Li |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | BeiGene (Shanghai) Co, Ltd Shanghai China |
| authorships[9].author.id | https://openalex.org/A5021223600 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4809-2851 |
| authorships[9].author.display_name | Zhiheng Xu |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210100450 |
| authorships[9].affiliations[0].raw_affiliation_string | BeiGene (Shanghai) Co, Ltd Shanghai China |
| authorships[9].institutions[0].id | https://openalex.org/I4210100450 |
| authorships[9].institutions[0].ror | https://ror.org/012v2c923 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210100450 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | BeiGene (China) |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Z. Xu |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | BeiGene (Shanghai) Co, Ltd Shanghai China |
| authorships[10].author.id | https://openalex.org/A5017221303 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-1938-8397 |
| authorships[10].author.display_name | Chi Ho To |
| authorships[10].affiliations[0].raw_affiliation_string | BeiGene USA, Inc San Mateo California USA |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | C. To |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | BeiGene USA, Inc San Mateo California USA |
| authorships[11].author.id | https://openalex.org/A5100695804 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5041-2287 |
| authorships[11].author.display_name | Limei Wang |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1343551460 |
| authorships[11].affiliations[0].raw_affiliation_string | University of Texas MD Anderson Cancer Center Houston Texas USA |
| authorships[11].institutions[0].id | https://openalex.org/I1343551460 |
| authorships[11].institutions[0].ror | https://ror.org/04twxam07 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1343551460 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | The University of Texas MD Anderson Cancer Center |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | L. M. Wang |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | University of Texas MD Anderson Cancer Center Houston Texas USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-06-18T00:00:00 |
| display_name | OT03 | BGB‐11417‐302, A PHASE 3, RANDOMIZED, DOUBLE‐BLIND STUDY OF SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB VERSUS PLACEBO + ZANUBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11157 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Chronic Lymphocytic Leukemia Research |
| related_works | https://openalex.org/W1859326399, https://openalex.org/W204855368, https://openalex.org/W2114261710, https://openalex.org/W1966127473, https://openalex.org/W2085650940, https://openalex.org/W2333338451, https://openalex.org/W2169836118, https://openalex.org/W2081991953, https://openalex.org/W3094582701, https://openalex.org/W2029502109 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1002/hon.70093_ot03 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S23714410 |
| best_oa_location.source.issn | 0278-0232, 1099-1069 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0278-0232 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Hematological Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Hematological Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/hon.70093_ot03 |
| primary_location.id | doi:10.1002/hon.70093_ot03 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S23714410 |
| primary_location.source.issn | 0278-0232, 1099-1069 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0278-0232 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Hematological Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70093_OT03 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Hematological Oncology |
| primary_location.landing_page_url | https://doi.org/10.1002/hon.70093_ot03 |
| publication_date | 2025-06-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 5 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5400000214576721 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.32298937 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |